Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer.
Kato K, Masuishi T, Fushiki K, Nakano S, Kawamoto Y, Narita Y, Tsushima T, Harada K, Kadowaki S, Todaka A, Yuki S, Tajika M, Machida N, Komatsu Y, Yasui H, Muro K, Kawakami T.
Kato K, et al. Among authors: tajika m.
ESMO Open. 2021 Aug;6(4):100179. doi: 10.1016/j.esmoop.2021.100179. Epub 2021 Jun 10.
ESMO Open. 2021.
PMID: 34119801
Free PMC article.